DeVinney Erick Wayne
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to DeVinney Erick Wayne. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| AXGN | Chief Innovation Officer | Sale | 19,517 | $31.21 | $609,126 | Dec 9, 2025 |
| AXGN | Chief Innovation Officer | Award / Grant | 40,000 | — | — | Dec 4, 2025 |
| AXGN | Chief Innovation Officer | Award / Grant | 2,500 | — | — | Sep 16, 2025 |
| AXGN | Chief Innovation Officer | Sale | 15,111 | $17.50 | $264,443 | Mar 16, 2025 |
| AXGN | Chief Innovation Officer | Tax Withholding | 8,296 | $18.35 | $152,232 | Feb 28, 2025 |
| AXGN | Chief Innovation Officer | Award / Grant | 2,500 | — | — | Feb 25, 2025 |
| AXGN | Chief Innovation Officer | Award / Grant | 2,500 | — | — | Sep 13, 2024 |
| AXGN | Chief Innovation Officer | Option Exercise | 3,000 | — | — | Mar 21, 2024 |
| AXGN | Chief Innovation Officer | Award / Grant | 50,000 | — | — | Mar 1, 2024 |
| AXGN | VP Peripheral Nerve Science | Disposition | 864 | $4.04 | $3,491 | Jul 18, 2023 |
| AXGN | VP Peripheral Nerve Science | Tax Withholding | 934 | $8.27 | $7,724 | Mar 16, 2023 |
| AXGN | VP Peripheral Nerve Science | Option Exercise | 750 | — | — | Dec 27, 2022 |
| AXGN | VP Peripheral Nerve Science | Tax Withholding | 10,784 | $9.44 | $101,801 | Dec 27, 2022 |
| AXGN | VP Peripheral Nerve Science | Disposition | 405 | $8.40 | $3,402 | Jul 18, 2022 |
| AXGN | VP Peripheral Nerve Science | Tax Withholding | 1,497 | $7.97 | $11,931 | Mar 16, 2022 |
| AXGN | VP Peripheral Nerve Science | Tax Withholding | 357 | $8.42 | $3,006 | Feb 15, 2022 |
| AXGN | VP Peripheral Nerve Science | Option Exercise | 750 | — | — | Dec 27, 2021 |
| AXGN | VP Peripheral Nerve Science | Option Exercise | 575 | — | — | Dec 20, 2021 |
| AXGN | VP Peripheral Nerve Science | Tax Withholding | 4,171 | $8.80 | $36,705 | Dec 15, 2021 |
| AXGN | VP Peripheral Nerve Science | Tax Withholding | 392 | $19.20 | $7,526 | Jul 19, 2021 |
| AXGN | VP of Clin. & Trans. Sciences | Option Exercise | 10,000 | $2.86 | $28,600 | Apr 28, 2021 |
| AXGN | VP, Clinical&Translational Sc | Award / Grant | 5,050 | — | — | Feb 17, 2021 |
| AXGN | VP, Clinical&Translational Sc | Award / Grant | 1,500 | — | — | Dec 29, 2020 |
| AXGN | VP, Clinical&Translational Sc | Sale | 147 | $16.42 | $2,414 | Dec 18, 2020 |
| AXGN | VP, Clinical&Translational Sc | Tax Withholding | 4,373 | $16.50 | $72,155 | Dec 15, 2020 |
| AXGN | VP, Clinical&Translational Sc | Option Exercise | 2,530 | $0.27 | $683 | Apr 28, 2020 |
| AXGN | VP, Clinical&Translational Sc | Award / Grant | 5,049 | — | — | Feb 18, 2020 |
| AXGN | VP, Clinical&Translational Sc | Tax Withholding | 281 | $16.73 | $4,701 | Dec 18, 2019 |
| AXGN | VP, Clinical&Translational Sc | Tax Withholding | 1,498 | $17.57 | $26,320 | Feb 15, 2019 |
| AXGN | VP, Clinical&Translational Sc | Option Exercise | 274 | $0.27 | $74 | Nov 13, 2018 |
| AXGN | VP, Clinical&Translational Sc | Option Exercise | 4,659 | $0.27 | $1,258 | Mar 14, 2017 |